Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income (Loss) per Common Share (Tables)

3 Months Ended

Feb. 28, 2019

The following table sets forth the calculation of basic and diluted earnings (loss) per share:


	For the three months ended February 28, 2019		For the three months ended February 28, 2018
Numerator:
Net Income (Loss)	$	275,877	($	2,530,072	)
Denominator:
Weighted-average shares outstanding-basic		7,801,333		7,105,135
Dilutive common shares issuable upon exercise of stock options		623,572		—

Weighted-average shares-diluted		8,424,905		7,105,135

Earnings (Loss) per share:
Basic	$	0.04	($	0.36	)

Diluted	$	0.03	($	0.36	)